How this link between the glycolytic and mesenchymal phenotypes fits with the canonical function of SMAD4 as a mediator of TGF-β signalling and the more epithelial character of SMAD4-deleted tumours [121] remains to be elucidated. Here, SMAD4 is linked to neoplasm.